Major Hydroxychloroquine Trial Shows No Prevention Benefits

A large, double-blind study examined 821 people who had been exposed to the virus. The drug was no better at stopping Covid-19 infection than a placebo.

Major Hydroxychloroquine Trial Shows No Prevention Benefits
A large, double-blind study examined 821 people who had been exposed to the virus. The drug was no better at stopping Covid-19 infection than a placebo.
Read More